Rifaximin

Rifaximin is an antibiotic used to treat travelers' diarrhea caused by certain types of bacteria. It is also used to treat irritable bowel syndrome (IBS) with diarrhea, and to reduce the risk of worsened brain function, or hepatic encephalopathy (HE), in people with liver failure. Rifaximin is in a class of medications called rifamycins. It works by stopping the growth of bacteria.

Rifaximin is an antibiotic medication belonging to the rifamycin class, but unlike other rifamycins like Rifampin or Rifapentine, it's not typically used to treat tuberculosis (TB). Here's a breakdown of the key uses and characteristics of Rifaximin:

Main applications:

  • Traveler's diarrhea: Rifaximin is a common treatment for traveler's diarrhea, which is caused by certain bacteria in the gut. It works by eliminating these bacteria and reducing symptoms like diarrhea, cramping, and bloating.
  • Hepatic encephalopathy (HE): This is a brain dysfunction caused by severe liver disease. Rifaximin can help prevent episodes of HE by reducing the production of ammonia, a toxin, in the gut.
  • Irritable bowel syndrome (IBS) with diarrhea (IBS-D): Rifaximin may be helpful in some cases of IBS-D by reducing gut bacteria thought to contribute to symptoms. However, it's not a first-line treatment, and its use in IBS-D is still under investigation.

How it works:

  • Rifaximin works similarly to other rifamycins, but with a key difference. It primarily acts locally within the gut, targeting bacteria there. This minimizes its absorption into the bloodstream, making it less likely to cause systemic side effects compared to some other rifamycins. By reducing the growth of harmful bacteria, Rifaximin helps alleviate symptoms associated with the conditions mentioned above.

Dosage and administration:

  • Rifaximin comes as tablets taken orally, typically for a short duration (3-7 days) for traveler's diarrhea or longer durations (weeks or months) for HE or IBS-D, depending on the specific condition and doctor's prescription.

Important considerations:

  • Not a first-line antibiotic: For many bacterial infections outside the gut, Rifaximin is not the preferred antibiotic due to its limited systemic absorption.
  • Antibiotic resistance: As with any antibiotic, overuse or misuse of Rifaximin can contribute to antibiotic resistance. It's important to take it exactly as prescribed by your doctor and complete the full course of treatment.
  • Potential side effects: Common side effects include nausea, vomiting, abdominal pain, and headache. Serious side effects are rare.
Anatomical Therapeutic Chemical Classification
D - Dermatologicals
D06 Antibiotics and chemotherapeutics for dermatological use
D06A - Antibiotics for topical use
D06AX Other antibiotics for topical use
Anatomical Therapeutic Chemical Classification
QG - Genito-urinary system and sex hormones
QG51 Antiinfectives and antiseptics for intrauterine use
QG51A - Antiinfectives and antiseptics for intrauterine use
QG51AA Antibacterials
Anatomical Therapeutic Chemical Classification
QJ - Antiinfectives for systemic use
QJ51 Antibacterials for intramammary use
QJ51X - Other antibacterials for intramammary use
QJ51XX Other antibacterials for intramammary use
External Links